(HealthDay)—Cardiometabolic outcomes and safety vary among different once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) treatments, according to a review published online Dec. 8 in the Annals of Internal Medicine.
Dec 8, 2015
0
1
An injection has helped reduce body weight and glucose levels in patients with diabetes and obesity in four weeks.
Aug 6, 2019
0
243
An international team of researchers led by Monash University in Australia has examined the associations of changes in body weight and waist circumference with all-cause and cause-specific mortality. In the paper, "Associations ...
The longevity and health improvements seen in animals on sulfur amino acid-restricted diets could translate to people, according to Penn State College of Medicine researchers who recently conducted a review of published studies. ...
Mar 29, 2018
1
350
With many teens heading back to school, peer pressure and academic expectations are once again a reality. These added pressures can cause ups and downs during what can be an already tumultuous time of life. For some teens, ...
Aug 15, 2022
0
10
An extremely slender and toned body, strict diet, low body fat and a BMI of 18.5, but still worried about her body shape. Are these the traits of a person with an eating disorder? A top athlete? Or both?
Dec 19, 2018
0
2
Diet and exercise fail for most adults who try to lose weight in the long-term. Today the American Gastroenterological Association (AGA) released new evidence-based guidelines strongly recommending that these patients with ...
Oct 20, 2022
0
5
Time-restricted eating (TRE) by eating early in the day (eTRE) is more effective for weight loss at 14 weeks than eating over a period of 12 or more hours daily, according to a study published online Aug. 8 in JAMA Internal ...
Aug 9, 2022
0
27
Northwestern Medicine scientists have developed an engineered probiotic capable of detecting inflammatory bowel disease, according to a study published in the Proceedings of the National Academy of Sciences.
Sep 12, 2023
0
226
In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored ...
Mar 20, 2021
0
30
